person · Reporting owner
Oliveira Steven Michael
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Benitec Biopharma Inc.BNTC · Entity 5596 | 10% owner | April 28, 2021 | December 09, 2021 |
| Forte Biosciences, Inc.TOCA · Entity 9529 | 10% owner | April 14, 2020 | April 14, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Benitec Biopharma Inc.
Report date April 28, 2021 · Filed December 09, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0,0001 per shareSEC Table I · non-derivative | IndirectThrough Nemean Asset Management, LLC | 768,123 |
Reported balance
After 2021-04-28 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2021-04-28 · Purchase · Acquired 100,000 · Balance 768,123 |
| Common Stock, par value $0,0001 per shareSEC Table I · non-derivative | IndirectThrough Nemean Asset Management, LLC | 791,000 |
Reported balance
After 2021-04-29 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-04-29 · Purchase · Acquired 22,877 · Balance 791,000 |
| Common Stock, par value $0,0001 per shareSEC Table I · non-derivative | IndirectThrough Nemean Asset Management, LLC | 911,000 |
Reported balance
After 2021-04-30 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2021-04-30 · Purchase · Acquired 120,000 · Balance 911,000 |
| Common Stock, par value $0,0001 per shareSEC Table I · non-derivative | IndirectThrough Nemean Asset Management, LLC | 951,500 |
Reported balance
After 2021-05-03 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2021-05-03 · Purchase · Acquired 40,500 · Balance 951,500 |
| Common Stock, par value $0,0001 per shareSEC Table I · non-derivative | IndirectThrough Nemean Asset Management, LLC | 989,447 |
Reported balance
After 2021-11-29 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2021-11-29 · Purchase · Acquired 37,947 · Balance 989,447 |
| Common Stock, par value $0,0001 per shareSEC Table I · non-derivative | IndirectThrough Nemean Asset Management, LLC | 1,000,000 |
Reported balance
After 2021-12-09 transaction · row 6
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 6 · 2021-12-09 · Purchase · Acquired 10,553 · Balance 1,000,000 |
Forte Biosciences, Inc.
Report date April 14, 2020 · Filed April 14, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Steven Oliveira Roth IRA | 2,873,450 |
Reported balance
After 2020-04-14 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2020-04-14 · Purchase · Acquired 74,301 · Balance 2,873,450 |
| Common StockSEC Table I · non-derivative | IndirectBy South Ocean Capital Management LLC | 1,266,000 |
Reported balance
Holding disclosure · report date 2020-04-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,266,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2021 Filed Dec 9, 2021 21:55 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon Stock, par value $0,0001 per share | 10,553 | $3.04 | $32,126.50 |
DisclosureSEC source: 0001104659-21-148207 · tm2135080-2_4.xml · nonDerivative · entry 6 Oliveira Steven Michael · CIK 0001358629 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Through Nemean Asset Management, LLC Disclosed balance after: 1,000,000 Read SEC document |
| November 29, 2021 Filed Dec 9, 2021 21:55 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon Stock, par value $0,0001 per share | 37,947 | $3.18 | $120,686.64 |
DisclosureSEC source: 0001104659-21-148207 · tm2135080-2_4.xml · nonDerivative · entry 5 Oliveira Steven Michael · CIK 0001358629 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Through Nemean Asset Management, LLC Disclosed balance after: 989,447 Read SEC document |
| May 03, 2021 Filed Dec 9, 2021 21:55 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon Stock, par value $0,0001 per share | 40,500 | $4.25 | $172,274.85 |
DisclosureSEC source: 0001104659-21-148207 · tm2135080-2_4.xml · nonDerivative · entry 4 Oliveira Steven Michael · CIK 0001358629 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Through Nemean Asset Management, LLC Disclosed balance after: 951,500 Read SEC document |
| April 30, 2021 Filed Dec 9, 2021 21:55 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon Stock, par value $0,0001 per share | 120,000 | $4.18 | $501,888.00 |
DisclosureSEC source: 0001104659-21-148207 · tm2135080-2_4.xml · nonDerivative · entry 3 Oliveira Steven Michael · CIK 0001358629 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Through Nemean Asset Management, LLC Disclosed balance after: 911,000 Read SEC document |
| April 29, 2021 Filed Dec 9, 2021 21:55 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon Stock, par value $0,0001 per share | 22,877 | $5.49 | $125,617.61 |
DisclosureSEC source: 0001104659-21-148207 · tm2135080-2_4.xml · nonDerivative · entry 2 Oliveira Steven Michael · CIK 0001358629 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Through Nemean Asset Management, LLC Disclosed balance after: 791,000 Read SEC document |
| April 28, 2021 Filed Dec 9, 2021 21:55 UTC | Benitec Biopharma Inc. BNTC · Entity 5596 | PurchaseCommon Stock, par value $0,0001 per share | 100,000 | $5.45 | $544,860.00 |
DisclosureSEC source: 0001104659-21-148207 · tm2135080-2_4.xml · nonDerivative · entry 1 Oliveira Steven Michael · CIK 0001358629 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Through Nemean Asset Management, LLC Disclosed balance after: 768,123 Read SEC document |
| April 14, 2020 Filed Apr 14, 2020 21:00 UTC | Forte Biosciences, Inc. TOCA · Entity 9529 | PurchaseCommon Stock | 74,301 | $1.19 | $88,418.19 |
DisclosureSEC source: 0001104659-20-046424 · tm2015887d1_4.xml · nonDerivative · entry 1 Oliveira Steven Michael · CIK 0001358629 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Steven Oliveira Roth IRA Disclosed balance after: 2,873,450 Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:17 UTC | Forte Biosciences, Inc. TOCA · Entity 9529 | PurchaseCommon Stock | 65,149 | $1.35 | $87,755.70 |
DisclosureSEC source: 0001104659-20-028555 · tv538796_4.xml · nonDerivative · entry 1 Oliveira Steven Michael · CIK 0001358629 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Steven Oliveira Roth IRA Disclosed balance after: 2,799,149 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.